About Emotional Brain
Emotional Brain is based in Almere, the Netherlands, and conducts fundamental scientific research into the causes of female sexual dysfunction and clinical research into treatment options. Two new on-demand drugs with blockbuster potential, Lybrido and Lybridos, are in development.
Moreover, Emotional Brain recently developed a novel method, based on genotyping using Single-Nucleotide Polymorphisms (SNPs) resulting in Phenotype Prediction Score (PPS) associated with traits and treatment effects. This innovative genetic method can be applied for the prediction whether someone is a responder or a non-responder to drug use (or traits). Other products are in early development stage. Over the years, Emotional Brain has published numerous well-cited papers in respected, peer-reviewed scientific journals such as Archives of General Psychiatry, the Journal of Sexual Medicine, Psychoneuroendocrinology and the British Journal of Clinical Pharmacology.
State of Ownership
Director at Exelion Bio-Pharmaceutical Consultancy BV, Exelion Bio-Pharmaceutical Consultancy BV
Sales Account Executive, Springer Nature
Business Development Executive, Nature Publishing Group, Springer Nature